Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 1
1994 3
1995 2
1996 3
1997 7
1998 5
1999 2
2000 7
2001 8
2002 11
2003 10
2004 8
2005 8
2006 10
2007 7
2008 11
2009 6
2010 10
2011 11
2012 17
2013 12
2014 18
2015 22
2016 9
2017 12
2018 19
2019 26
2020 27
2021 29
2022 25
2023 22
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

325 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Kopyltsov E, Méndez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Alonso Gordoa T, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing D, Choueiri TK; CLEAR Trial Investigators. Motzer R, et al. N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13. N Engl J Med. 2021. PMID: 33616314 Clinical Trial.
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
Reply by Authors.
Tafuri A, Iwata A, Shakir A, Iwata T, Gupta C, Sali A, Sugano D, Mahdi AS, Cacciamani GE, Kaneko M, Cai J, Ukimura O, Duddalwar V, Aron M, Gill IS, Palmer SL, Abreu AL. Tafuri A, et al. Among authors: ukimura o. J Urol. 2021 Aug;206(2):297. doi: 10.1097/JU.0000000000001766.02. Epub 2021 Jul 2. J Urol. 2021. PMID: 34235960 No abstract available.
Reply by Authors.
Tafuri A, Iwata A, Shakir A, Iwata T, Gupta C, Sali A, Sugano D, Mahdi AS, Cacciamani GE, Kaneko M, Cai J, Ukimura O, Duddalwar V, Aron M, Gill IS, Palmer SL, Abreu AL. Tafuri A, et al. Among authors: ukimura o. J Urol. 2021 Aug;206(2):426. doi: 10.1097/JU.0000000000001792.03. Epub 2021 Jun 1. J Urol. 2021. PMID: 34060336 No abstract available.
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
Motzer RJ, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Alekseev B, Rha SY, Merchan J, Goh JC, Lalani AA, De Giorgi U, Melichar B, Hong SH, Gurney H, Méndez-Vidal MJ, Kopyltsov E, Tjulandin S, Gordoa TA, Kozlov V, Alyasova A, Winquist E, Maroto P, Kim M, Peer A, Procopio G, Takagi T, Wong S, Bedke J, Schmidinger M, Rodriguez-Lopez K, Burgents J, He C, Okpara CE, McKenzie J, Choueiri TK; CLEAR Trial Investigators. Motzer RJ, et al. J Clin Oncol. 2024 Apr 10;42(11):1222-1228. doi: 10.1200/JCO.23.01569. Epub 2024 Jan 16. J Clin Oncol. 2024. PMID: 38227898 Free article. Clinical Trial.
Reply by Authors.
Oishi M, Gill IS, Tafuri A, Shakir A, Cacciamani GE, Iwata T, Iwata A, Ashrafi A, Park D, Cai J, Desai M, Ukimura O, Bahn DK, Abreu AL. Oishi M, et al. Among authors: ukimura o. J Urol. 2019 Dec;202(6):1198. doi: 10.1097/01.JU.0000582672.51608.a4. Epub 2019 Sep 16. J Urol. 2019. PMID: 31524574 No abstract available.
Editorial comment.
de Castro Abreu AL, Ukimura O, Desai MM. de Castro Abreu AL, et al. Among authors: ukimura o. Urology. 2014 Jul;84(1):104-5. doi: 10.1016/j.urology.2014.01.056. Epub 2014 May 10. Urology. 2014. PMID: 24813069 No abstract available.
Focal therapy of localized prostate cancer.
Fujihara A, Ukimura O. Fujihara A, et al. Among authors: ukimura o. Int J Urol. 2022 Nov;29(11):1254-1263. doi: 10.1111/iju.14991. Epub 2022 Aug 22. Int J Urol. 2022. PMID: 35996758 Review.
325 results